Skip to content

Agenda

Thursday, November 9th, 2017
6:45 - 7:30 AM

Breakout Check-in & Networking Breakfast

7:30 - 8:15 AM

Breakout Sessions

OD/MD Collaboration & Competition (Signup Closed)

Focusing on the relationship between the MD and OD and how it impacts innovation

Co-moderator: Daniel Durrie, MD, President - Durrie Vision
Co-moderator: Eric Donnenfeld, MD, Clinical Professor of Ophthalmology – NYU/ Ophthalmic Consultants of Long Island

Joe Boorady, OD, President & CEO – TearScience, Johnson & Johnson Vision
James Thimons, OD, Clinical Director - Ophthalmic Consultants of Connecticut

MIGS/Glaucoma (Signup Closed)

Exploring the background and current state of MIGs: Successes, problems and future

Moderator: Richard Lewis, MD, Co-Founder - Sacramento Eye Consultants/Chief Medical Officer - Aerie Pharmaceuticals

Ron Bache, President & CEO - Bache, Inc.
Chris Calcaterra, Chief Commercial Officer – Glaukos Corporation
Ram Palanki, PharmD, SVP of Commercial, Americas - Santen

Private Equity & Private Practice (Signup Closed)

The role of private equity and consolidation in the future of ophthalmic care

Moderator: Richard Lindstrom, MD, Founder & Attending Surgeon - Minnesota Eye Consultants

Bruce Maller, President & CEO - BSM Consulting
Sami Abbasi, CEO - Unifeye Vision Partners
Mark Rosenberg, MD, Vice Chairman Board of Directors - American Vision Partners

A Discussion with Dr. Malvina Eydelman (Signup Closed)

Moderator: Kuldev Singh, MD, Professor of Ophthalmology - Stanford University

Nicholas Tarantino, OD, Chief Clinical & Regulatory Officer, Head R&D - AcuFocus
Malvina Eydelman, MD, Director, Division of Ophthalmic and Ear, Nose & Throat Devices – FDA

A Discussion with Dr. Wiley Chambers (Signup Closed)

Co-moderator: Gary Novack, PhD, President - PharmaLogic Development
Co-moderator: Peter Kaiser, MD, Professor of Ophthalmology - Cole Eye Institute

Wiley Chambers, MD, Deputy Director, Division of Transplant & Ophthalmology Products Center for Drug Evaluation & Research – FDA

Dry Eye - History and Current Activity (Signup Closed)

Moderator: Edward Holland, MD, Director, Cornea Services - Cincinnati Eye Institute

Kim Brazzell, PhD, Chief Medical Officer - Kala Pharmaceuticals
Susan Benton, Global New Products Lead & Global Product Strategy, Ophthalmics - Shire
John Sheppard, MD, Professor of Ophthalmology, Microbiology & Molecular Biology - Eastern Virginia Medical School

Retina Update – Interpreting and Looking Beyond the Highlights of 2017 (Signup Closed)

Moderator: Pravin Dugel, MD, Managing Partner - Retinal Consultants of Arizona

Jay Duker, MD, Founder - Hermera Biosciences
David S. Boyer, MD - Retina-Vitreous Associates Medical Group
Jeffrey Heier, MD, Co-President & Medical Director - Ophthalmic Consultants of Boston

7:45 - 8:30 AM

General Check-in & Networking Breakfast

Sponsored By:

8:30 - 8:40 AM

Welcome and Chairman’s 2017 Year in Review

Emmett T. Cunningham Jr., MD, PhD, MPH, Managing Director – Clarus Funds

8:40 - 9:43 AM

Company Showcase 1

Co-Moderated By:
Jason Menzo, VP, Business Unit Head - Ophthalmics - Sun Pharmaceuticals
Samir Tari, MD, Senior Medical Director - Astellas

8:40 - 8:47 | AGTC | Sue Washer, President & CEO
8:47 - 8:54 | GenSight Biologics | Barrett Katz, MD, MBA, Chief Medical Officer
8:54 - 9:01 | Nightstar | David Fellows, CEO
9:01 - 9:08 | jCyte | David S. Boyer, MD, Investigator
9:08 - 9:15 | Bio-Tissue | Scheffer Tseng, MD, PhD, Medical Director & Chief Technology Officer
9:15 - 9:22 | Novaliq GmbH | Christian Roesky, CEO & Managing Director
9:22 - 9:29 | pSivida | Nancy Lurker, President & CEO
9:29 - 9:36 | EyeGate Pharmaceuticals | Stephen From, CEO
9:36 - 9:43 | Aciont | John Higuchi, CEO

9:43 - 10:39 AM

Company Showcase 2

Co-Moderated By:
Costin Curatu, Head, Search and Evaluation - Surgical , Business Development & Licensing - Alcon
Tracy Valorie, SVP & General Manager - Bausch + Lomb

9:43 - 9:50 | AcuFocus | Yari Mitchell, VP, Medical Affiars & Business Strategy
9:50 - 9:57 | Avedro | Reza Zadno, PhD, President & CEO
9:57 - 10:04 | Mynosys Cellular Devices | John Hendrick, President & CEO
10:04 - 10:11 | PowerVision | Barry Cheskin, President, CEO & Co-Founder
10:11 - 10:18 | iStar Medical SA | Michel Vanbrabant, CEO
10:18 - 10:25 | Ivantis | Dave Van Meter, President & CEO
10:25 - 10:32 | EBS Technologies | Karl Schweitzer, CEO
10:32 - 10:39 | TrueVision Systems | Burton Tripathi, PhD, EVP of R&D and Chief Technology Officer

10:39 - 11:00 AM

Morning Networking & Refreshment Break

Sponsored By:

11:00 - 12:10 PM

Company Showcase 3

Co-Moderated By:
Melissa Liew, MD, VP & US Medical Head, Ophthalmology - Novartis
Andrew Stewart, Executive Director - Allergan

11:00 - 11:07 | Aura Biosciences | Elisabet de los pinos, PhD, CEO
11:07 - 11:14 | ONL Therapeutics | John Freshley, President & CEO
11:14 - 11:21 | Aerpio Pharmaceuticals | Joseph Gardner, President & CEO
11:21 - 11:28 | KalVista Pharmaceuticals | Andrew Crockett, CEO
11:28 - 11:35 | Ocunexus Therapeutics | Brian Levy, CEO
11:35 - 11:42 | Allegro Ophthalmics | Vicken Karageozian, MD, President & Chief Medical Officer
11:42 - 11:49 | Iconic Therapeutics | William Greene, MD, CEO
11:49 - 11:56 | Graybug Vision | Jeff Cleland, PhD, President & CEO
11:56 - 12:03 | Ocular Therapeutix | Antony Mattessich, President & CEO
12:03 - 12:10 | Notal Vision | Susan Orr, Chief Medical Officer & VP, Medical Affairs

12:10 - 12:40 PM

Industry Insights into Innovation 2017

Focusing on current trends in innovation and how the morning showcase companies fit in.

Participants:
Robert Dempsey, Group Vice President, Head of Global Ophthalmics Franchise – Shire
Jason Ehrlich, MD, PhD, Global Head, Clinical Ophthalmology Product Development – Genentech
Jane Rady, VP, Business Development, Surgical - Johnson & Johnson Vision
Calvin Roberts, MD, SVP, Chief Medical Officer - Bausch + Lomb
Dirk Sauer, PhD, Global Development Unit Head, Ophthalmology Unit - Novartis Pharma AG
Naveed Shams, MD, PhD, Sr. Corporate Officer, Head, Global R&D and Chief Science Officer - Santen Pharmaceuticals Ltd.

Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Managing Director – Clarus Funds

12:40 - 1:30 PM

Networking Lunch

Sponsored By:
Johnson & Johnson Vision

1:30 - 1:45 PM

OIS Industry Tribute

Growth Through Metamorphosis: The Story of AMO

1:45 - 2:15 PM

Challenges in Innovation: What Would You Do?

Case studies in real life tough decisions with panel discussion of actual outcomes.

Early stage financing: Randy Alexander, Chairman - ReVision Optics
FDA challenges: Reza Zadno, PhD, President & CEO - Avedro
Commercialization: Bernie Haffey, President - 2020 Management Consulting

Moderated By:
Gilbert H. Kliman, MD, Managing Director - InterWest Partners

2:15 - 2:20 PM

Ophthalmic Innovation 2017 - “A View from the AAO”

David W. Parke II, MD, CEO - American Academy of Ophthalmology (AAO)

2:20 - 2:25 PM

Ophthalmic Innovation 2017 - “A View from the NEI”

Mala Dutta, PhD, Lead, Office of Translational Research - National Eye Institute, NIH

2:25 - 2:55 PM

Blended Careers: Industry and Medicine

Highlighting the migration of KOLs into industry

Participants:
Emmett T. Cunningham Jr., MD, PhD, MPH, Managing Director – Clarus Funds
Ron Kurtz, MD, President & CEO - RxSight
Stephen S. Lane, MD, Chief Medical Officer and Head Global Franchise Clinical Strategy - Alcon/Medical Director - Associated Eye Care
Jai G. Parekh, MD, MBA, Founder - EyeCare Consultants of NJ / VP, Global Medical Affairs Office of CMO, Eyecare & Dermatology -Allergan
Rajesh Rajpal, MD, Chief Medical Officer - Avedro
Steve Schallhorn, MD, Chief Medical Officer - Carl Zeiss Meditec
Jonathan Talamo, MD, Chief Medical Officer, VP Medical & Clinical Affairs - Johnson & Johnson Vision

Moderated By:
Richard Lindstrom, MD, Founder & Attending Surgeon - Minnesota Eye Consultants

2:55 - 3:20 PM

Afternoon Networking & Refreshment Break

Sponsored By:

3:20 - 3:26 PM

Private Funding Trends Presentation

Jonathan Norris, Managing Director - SVB

3:26 - 3:32 PM

A View of the Public Ophthalmology Market

Andrew Gitkin, Head of West Coast Biotechnology Investment Banking - Piper Jaffray

3:32 - 3:35 PM

2017 Update of OIS Index

Michael Lachman, President - EyeQ Research

3:35 - 4:35 PM

Public Device and BioPharma Company Showcase

Moderated By:
Michael Lachman, President - EyeQ Research

3:35 - 3:45 | Aerie Pharmaceuticals | Tom Mitro, COO
3:45 - 3:55 | Alimera Sciences | Dan Myers, CEO
3:55 - 4:05 | Clearside Biomedical | Daniel White, President & CEO
4:05 - 4:15 | Kala Pharmaceuticals | Mark Iwicki, Chairman & CEO
4:15 - 4:25 | Ophthotech Corporation | Glenn Sblendorio, President & CEO
4:25 - 4:35 | Glaukos Corporation | Joe Gilliam, CFO & SVP of Corporate Development

4:35 - 5:05 PM

Masters of the Industry

Industry Executives share how they manage innovation, integration and other challenges facing big companies today.

Participants:
Michael Ball, CEO - Alcon
Tom Frinzi, Worldwide President, Surgical - Johnson & Johnson Vision
Dr. Rafiq Hasan, VP & Global Head of Ophthalmology - Bayer
William J. Link, PhD, Managing Director - Versant Ventures
Ludwin Monz, PhD, President & CEO - Carl Zeiss Meditec AG
Brent Saunders, Chairman, President & CEO - Allergan

Moderated By:
Jim Mazzo, Global President Ophthalmic Devices - Carl Zeiss Meditec

5:05 - 5:10 PM

Closing Remarks

William J. Link, PhD, Managing Director - Versant Ventures

5:10 - 6:10 PM

Networking Reception

Sponsored By:
Alcon

Scroll To Top